Is Wurster Processing the Right Choice for My Multiparticulate Modified Release Dosage Form?
Wurster processing is an extremely versatile pharmaceutical development and manufacturing technique for producing multiparticulate modified release (such as extended or controlled release) dosage forms. However, it does have certain limitations and, in some cases, other strategies would be better.
Recro has been developing and manufacturing multiparticulate dosage forms since the mid-1980s and has used Wurster processing since the late 1990s. Our scientists share decades of experience developing and manufacturing modified release multiparticulate formulations using Wurster processing. From formulation and analytical development to process and method validation, even for DEA controlled substances, our scientists will deliver a modified release formulation and process that exceeds your expectations.
In this white paper, Richard Sidwell tells you what you need to consider to determine whether Wurster processing is right for your multiparticulate modified release dosage form.